On the sidelines of the press conference entitled “Asthma issue resolved?” held in Milan and promoted by Chiesi Italia, the Italian branch of the Chiesi Group, concerning the innovative made in Italy research on a new drug, capable of giving a triple benefit to asthmatic patients, Paola Rogliani intervened – professor of respiratory system diseases, university Tor Vergata in Rome.
#Asthma #Rogliani #Triple #inhalation #therapy #situations #severe #asthma